Đang chuẩn bị liên kết để tải về tài liệu:
Immune- and miRNA-response to recombinant interferon beta-1a: A biomarker evaluation study to guide the development of novel type I interferon- based therapies

Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ

The innate immune receptor RIG-I detects viral RNA within the cytosol of infected cells. Activation of RIG-I leads to the induction of antiviral cytokines, in particular type I interferon, the inhibition of a T(H)17 response as well as to the suppression of tumor growth. | Immune- and miRNA-response to recombinant interferon beta-1a: A biomarker evaluation study to guide the development of novel type I interferon- based therapies

TÀI LIỆU LIÊN QUAN

Prevalence of immune-related adverse events and anti-tumor efcacy following immune checkpoint inhibitor therapy in Japanese patients with various solid tumors

NUTRITION AND IMMUNE FUNCTION

Ebook Basic immunology functions and disorders of the immune system (4th edition): Part 1

Ebook How the immune system works (5th edition): Part 2

A study on the use of carbon quantum dots on hCG immune analysis

Radiotherapy-induced anti-tumor immune response and immune-related adverse events in a case of recurrent nasopharyngeal carcinoma undergoing anti-PD-1 immunotherapy

Profiling networks of distinct immune-cells in tumors

The feasibility of proteomics sequencing based immune-related prognostic signature for predicting clinical outcomes of bladder cancer patients

AQP9 and ZAP70 as immune-related prognostic biomarkers suppress proliferation, migration and invasion of laryngeal cancer cells

Integrated analysis of the relation to tumor immune microenvironment and predicted value of Stonin1 gene for immune checkpoint blockage and targeted treatment in kidney renal clear cell carcinoma